| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |